Sign In
Get Clay Free →

Suggestions

    Scott Pancoast

    CEO and Founder at Zylö Therapeutics; Previously Board Member at DermTech; Lpath; Vista Medical; Chemed Subsidiary

    Professional Background

    Scott Pancoast stands out as an accomplished executive with a rich tapestry of experience in venture capital and leadership across numerous sectors. His career is marked by a strong dedication to fostering innovation and guiding companies through pivotal growth phases. With extensive experience as a CEO, Scott has held the helm of three different organizations, showcasing his adaptability and commitment to steering companies towards success.

    In addition to his roles as CEO, Scott has a wealth of experience as an interim CEO, having taken the lead in six different companies during transitional periods. This unique capability allows him to bring a fresh perspective and strategic insight to organizations, propelling them not only to stabilize but to thrive. His substantial board-member experience, having served on over 15 boards, including four publicly traded entities, equips him with a deep understanding of corporate governance, strategic planning, and the complexities of regulatory environments.

    Scott's capacity for capital mobilization is equally impressive; he has been involved in about 40 separate capital raises, often spearheading initiatives to secure necessary funding for growth and development. His expertise in providing a compelling vision coupled with the aptitude to gather the right resources underscores his strategic acumen and leadership effectiveness.

    Education and Achievements

    Scott Pancoast pursued a high-caliber education that laid the foundation for his successful career. He studied for an MBA in General Management at the prestigious Harvard Business School, a program renowned for producing industry leaders who excel in strategic thinking and innovative management practices. Prior to this, he earned his Bachelor of Arts in Economics from the University of Virginia, which provided him with a solid grounding in economic principles and financial acumen.

    His educational background, combined with his professional experiences, has enabled Scott to develop a unique skill set that blends analytical rigor with creative problem-solving. This powerful combination informs his approach to leadership and strategy, making him a sought-after executive in various industries.

    Notable Positions and Contributions

    Throughout his career, Scott has made significant contributions to several organizations, reflecting his versatile leadership and strategic insights:

    • CEO and Founder at Zylö Therapeutics: In his current role, Scott leads the innovative organization dedicated to developing cutting-edge therapeutic solutions, utilizing advanced technology to enhance the delivery and efficacy of treatments.

    • Member of the Board of Directors at DermTech: As a board member of this Nasdaq-listed company, Scott contributes to strategic decisions that drive growth and development in the rapidly evolving field of dermatological and genetic testing.

    • Chairman at Vaxiion Therapeutics, Inc.: In this leadership position, he has been instrumental in guiding the company’s strategic vision and operational execution, positioning it for success in the biotechnology industry.

    • Board Member & Interim CEO at Neology Inc.: Scott's dual role here showcases his capacity to stabilize company operations while leading strategic initiatives during pivotal periods. His leadership has been vital for organizations navigating complex challenges.

    • Board Member (2000-2003) and Chair (2002-2003) at American Heart Association (Research Roundtable): Scott has played a crucial role in promoting heart health awareness and funding important research initiatives that contribute to public health improvements.

    • Former CEO, Chairman, and Board Member at Lpath: Scott's leadership at Lpath highlights his commitment to innovation in the biotechnology sector, guiding the company with vision and strategic insight.

    • Member of the Board & Interim CEO at EPIC Solutions: His leadership provided critical direction during transitional phases, ensuring continuity and focus on strategic goals.

    • Engaged in various roles in Prisa Networks, San Diego Venture Group, and Endonetics: Scott's extensive board experience reflects his passion for nurturing startups and established companies, enhancing their strategic direction and operational performance.

    • Former Executive Vice President at Western States Investment Group and Senior Vice President at Chemed Corporation: These positions bolstered his expertise in investment strategies and corporate management, ultimately enhancing his calculations in venture capitalism and beyond.

    Related Questions

    How did Scott Pancoast develop his expertise in venture capital?
    What strategies has Scott Pancoast implemented to successfully raise capital for startups?
    In what ways has Scott Pancoast's education at Harvard Business School influenced his leadership style?
    What are some of the most significant challenges Scott Pancoast faced as an interim CEO?
    How has Scott Pancoast contributed to the growth of Zylö Therapeutics since founding the company?
    What impact did Scott Pancoast have as Chair of the American Heart Association (Research Roundtable) during his tenure?
    What innovative approaches has Scott Pancoast introduced during his time as a CEO in the biotechnology sector?
    How does Scott Pancoast envision the future of healthcare innovation through his roles in various organizations?
    Scott Pancoast
    Add to my network

    Location

    Greenville, South Carolina, United States